Journal of Generic Medicines

Patent-related barriers to market entry for generic medicines in the European Union: A review of weaknesses in the current European patent system and their impact on market access of generic medicines

Kristof Roox

Patent-related barriers to market entry for generic medicines in the European Union: A review of weaknesses in the current European patent system and their impact on market access of generic medicines

Journal of Generic Medicines 5, 255 (July 2008). doi:10.1057/jgm.2008.24

Authors: Kristof Roox, Julia Pike, Andrew Brown, Stefan Becker, György Thaler, Lidia Mallo &

Veterinary generics: An enigma among niche markets

Jean Hoffman — July 8, 2008

Veterinary generics: An enigma among niche markets

Journal of Generic Medicines 5, 281 (July 2008). doi:10.1057/jgm.2008.17

Authors: Jean Hoffman, Christina Perkins &

The single bioequivalence study's impact on the dossier broker

Richard L DiCicco — August 5, 2008

The single bioequivalence study's impact on the dossier broker

Journal of Generic Medicines 5, 291 (July 2008). doi:10.1057/jgm.2008.21

Author: Richard L DiCicco &

Continuing equivalence: Is there an end to the story?

Roger L Williams — July 15, 2008

Continuing equivalence: Is there an end to the story?

Journal of Generic Medicines 5, 297 (July 2008). doi:10.1057/jgm.2008.19

Authors: Roger L Williams, Vinod P Shah &

Prevailing against cost-leader competitors in the pharmaceutical industry

Gil Tomer — July 8, 2008

Prevailing against cost-leader competitors in the pharmaceutical industry

Journal of Generic Medicines 5, 305 (July 2008). doi:10.1057/jgm.2008.15

Author: Gil Tomer &

Evaluating community pharmacists' perceptions and practices on generic medicines: A pilot study from Peninsular Malaysia

Zaheer-Ud din Babar — May 20, 2008

Evaluating community pharmacists' perceptions and practices on generic medicines: A pilot study from Peninsular Malaysia

Journal of Generic Medicines 5, 315 (July 2008). doi:10.1057/jgm.2008.10

Authors: Zaheer-Ud din Babar, Ahmed Awaisu &

Abbott v Torpharm: The Contours of Contempt

Frederick H Rein — May 13, 2008

Abbott v Torpharm: The Contours of Contempt

Journal of Generic Medicines 5, 331 (July 2008). doi:10.1057/jgm.2008.11

Authors: Frederick H Rein & Joseph B Crystal

Biogen insufficiency explained; Alendronate in Netherlands; Behaviour relevant to injunction; Perindopril evergreening criticised; ‘Negative Term’ SPCs'; new dosage regimes

Michael Burdon — July 8, 2008

Biogen insufficiency explained; Alendronate in Netherlands; Behaviour relevant to injunction; Perindopril evergreening criticised; ‘Negative Term’ SPCs'; new dosage regimes

Journal of Generic Medicines 5, 341 (July 2008). doi:10.1057/jgm.2008.16

Authors: Michael Burdon, Rebecca Singleton, Catherine Katzka, Jade MacIntyre & Siddharth Kusumakar

Tropical disease priority review vouchers: Potential incentives and opportunities for generic manufacturers

Joshua A Ehrenfeld — July 1, 2008

Tropical disease priority review vouchers: Potential incentives and opportunities for generic manufacturers

Journal of Generic Medicines 5, 353 (July 2008). doi:10.1057/jgm.2008.14

Author: Joshua A Ehrenfeld

EU Legal and Regulatory Update

June 17, 2008

EU Legal and Regulatory Update

Journal of Generic Medicines 5, 357 (July 2008). doi:10.1057/jgm.2008.12

Formulations patents in pharmaceutical development

Leighton Howard — July 29, 2008

Formulations patents in pharmaceutical development

Journal of Generic Medicines 5, 365 (July 2008). doi:10.1057/jgm.2008.18

Author: Leighton Howard

Generic Pharmaceutical Patent and FDA Law, 2008 Edition

Richard DiCicco

Generic Pharmaceutical Patent and FDA Law, 2008 Edition

Journal of Generic Medicines 5, 371 (July 2008). doi:10.1057/jgm.2008.13

Author: Richard DiCicco